Galectin Therapeutics Inc.
NASDAQ:GALT · NASDAQ Capital Market
+$0.05 today
Vol 0.26M · Avg 0.32M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+13.91%
Period High
$6.51
Period Low
$2.08
Latest
$2.83
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alpha Tau Medical Ltd.
NASDAQ:DRTS
$860.81M
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$852.56M
Design Therapeutics, Inc.
NASDAQ:DSGN
$766.98M
Aura Biosciences, Inc.
NASDAQ:AURA
$398.04M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$355.17M
DiaMedica Therapeutics Inc.
NASDAQ:DMAC
$307.67M
Altimmune, Inc.
NASDAQ:ALT
$240.50M
I-Mab
IMAB
$235.66M
Quantum-Si incorporated
NASDAQ:QSI
$196.70M
enGene Holdings Inc.
NASDAQ:ENGN
$88.06M
What is the latest GALT filing?
The latest filing shown is 4 dated May 28, 2026.
How many recent filings does GALT have?
Intrinsic Alpha currently shows 20 recent filings for GALT.
Explore More
Continue the stock analysis
Jump to another research area for this company.